“And a lack of sharing of licenses, technology and know-how by pharmaceutical companies meant manufacturing capacity went unused.” At the end of …
“And a lack of sharing of licenses, technology and know-how by pharmaceutical companies meant manufacturing capacity went unused.” At the end of …